Method for identifying substances useful for treating inflammation using the response element to the i.kappa.b.alpha. ror receptor
CA 2420233 A1 · Owner: Delerive, Philippe · Inventors: Staels, Bart; Delerive, Philippe
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention concerns a method for identifying substances useful for treating inflammation characterised in that it comprises the following steps: (a) contacting said substance with a nucleic acid construct containing the response element to the ROR receptor of the promoter of the I.kappa.B.alpha. gene in conditions suitable for allowing said substance to be fixed on the response element; (b) measuring the possible fixing of said substance on the response element or the transcriptional activity of the response element or of a promoter containing it; (c) optionally comparing the measurement of step (b) with a measurement carried out in conditions similar to those of steps (a) and (b) but …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 22, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended August 22, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 22, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.